Latest From Biotech Now

Greenwood Highlights Need for Bold Action to Address Alzheimer’s

Jim Greenwood

Last week, Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), participated and spoke at the #C4CT (Coalition for Concussion Treatment) Concussion Awareness Summit hosted at the United Nations in New York City. The day-long event explored links between Traumatic Brain Injury and Alzheimer’s Disease and featured leading policy experts, biotechnology entrepreneurs, academics,  investment firms, medical researchers, diplomats and professional athletes. The event was hosted by Brewer Sports International (BSI), a multi-faceted global Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Puerto Rico: The New Hub for Ag-Biotech Innovation

Corn

 “Biotechnology Innovation—the union of scientific discovery and capital can flourish in a supportive research and regulatory environment. Key policy principles will help facilitate the discovery, development, and commercialization of biotech products that will fight disease, feed the hungry and improve the environment”-BIO 2014 A quote that wholly describes the agricultural climate of Puerto Rico.  The country offers a perfect location, climate, great soil quality, inviting regulatory system, three pronounced academic/research programs and friendly biotech work Read More >

Food And Agriculture  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , ,

1 of the 2,000 Articles Supporting GMO Safety

USDA-ERS-rpt-0214a115x76

On Thursday July 24, 2014, The Huffington Post published a blog titled Genetically-Modified Organisms (GMOs) Have NOT Been Proven Safe. The title alone made me question the author’s integrity. Personally, I was expecting the author to cite some academic sources to make such a claim; after reading the blog, it was clear that the author’s title did not reflect the true narrative of her logic. Her main argument for making this bold claim is that Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Treating Hepatitis C: Too Costly Not to Act

CHI

Today, The Hill published an op-ed – Treating hepatitis C: Too costly not to act – by California Healthcare Institute’s Todd Gillenwater on the value of breakthrough Hepatitis C medicines that cure the disease in the majority of patients. As Gillenwater asserts, “New hepatitis C drugs mark a paradigm shift – from a model of somewhat iffy but costly chronic care to a model of short-term curative treatment with equal or slightly lower costs paid Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

DOE Biomass 2014 Conference Highlights Renewable Chemicals

Brent Erickson

This week, the U.S. Department of Energy’s Bioenergy Technologies Office (BETO) hosted its seventh annual conference—Biomass 2014: Growing the Future Bioeconomy, focusing on innovative technologies, financing strategies, and public policies needed to grow the bioeconomy. Brent Erickson, executive vice president of BIO’s Industrial and Environmental Section, spoke at a Plenary Session titled Policy Challenges and Opportunities for Growing the Bioeconomy, at which the head’s of several Washington trade groups discussed meeting the challenges and leveraging opportunities that Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,